Ads
    Related paper
  1. Refractory Immune Checkpoint Inhibitor Colitis successfully managed with Tacrolimus |Biomedgrid
  2. Leading the Charge by Dr. Rahul Ravilla: The Newer Immune-Related Side-Effects Impacts Continuity of Care in Individuals with Cancer on Immune Checkpoint Inhibitors
  3. Use of tacrolimus ointment (0.03%) for refractory VKC
  4. LCPT in tacrolimus fast-metabolizing pancreas recipients compared to high-dose prolonged release tacrolimus versus non-fast metabolizers: a singlecenter experience |Biomedgrid
  5. Sprue-like Intestinal Disease Induced by Checkpoint Inhibitor Immunotherapy
  6. Risk of myocarditis in patients with cancer treated with immune checkpoint inhibitors
  7. Massive pleural effusion from pancreaticopleural fistula: Successfully managed with endoscopic pancreatic duct stenting
  8. Adenoid facies and chronic refractory rhinosinusitis managed by endoscopic-assisted adenoidectomy
  9. Impact of single nucleotide polymorphisms of immune checkpoint CTLA-4 (SNP rs231775 and rs5742909) in susceptibility to Hashimoto's thyroiditis patients
  10. MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer